Features of the Treatment of Coronavirus Infection Caused by Covid-2019: A Randomized, Double-Blind, Placebo-Controlled Study

Abstract

This article presents data on the treatment of coronavirus infection with a new unique drug based on G. Lucidum and Alkhadai according to a randomized, double-blind, placebo-controlled trial. There was a significant improvement in the course of the disease, prognosis and outcome after the use of the drug, in contrast to traditional methods of treating coronavirus infection caused by COVID-19.